Article Information
History
- April 5, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jorge Barbazan1,†,
- Carlos Pérez-González1,†,
- Manuel Gómez-González2,
- Mathieu Dedenon3,
- Sophie Richon1,
- Ernest Latorre2,
- Marco Serra3,
- Pascale Mariani4,
- Stéphanie Descroix3,
- Pierre Sens3,
- Xavier Trepat2,5,6,7,* and
- Danijela Matic Vignjevic1,*
- 1Institut Curie, PSL Research University, CNRS UMR 144, F-75005 Paris, France
- 2Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute for Science and Technology (BIST), 08028 Barcelona, Spain
- 3Institut Curie, PSL Research University, CNRS UMR 168, F-75005 Paris, France
- 4Institut Curie, Department of surgical oncology, Curie Institute, F-75005 Paris, France
- 5Facutltat de Medicina, Universitat de Barcelona, 08036 Barcelona, Spain
- 6Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
- 7Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 08028 Barcelona, Spain
- ↵*Corresponding authors. Email: danijela.vignjevic{at}curie.fr, Email: xtrepat{at}ibecbarcelona.eu
↵† These authors contributed equally to this work
Posted April 05, 2021.
Cancer-associated fibroblasts actively compress cancer cells and modulate mechanotransduction
